The results of treatment with idarubicin in childhood acute nonlymphoblastic leukemia


Sasmaz I. , Tanyeli A., Bayram I. , Antmen B. , Yilmaz L., Kucukosmanoglu O., et al.

TURKISH JOURNAL OF PEDIATRICS, cilt.46, ss.32-37, 2004 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 46 Konu: 1
  • Basım Tarihi: 2004
  • Dergi Adı: TURKISH JOURNAL OF PEDIATRICS
  • Sayfa Sayısı: ss.32-37

Özet

Anthracycline and cytosine arabinoside are used in combination as the standard therapy for remission induction of acute nonlymphoblastic leukemia. Idarubicin, a synthetic daunorubicin analogue, shows an improved spectrum activity and diminishes acute or chronic toxicity when compared with the other anthracyclines. This study has been carried out in our clinic in order to evaluate the efficiency of the acute nonlymphoblastic leukemia protocol which includes idarubicin.